Patents by Inventor Kenneth M. Curry

Kenneth M. Curry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
    Publication number: 20230157868
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: January 9, 2023
    Publication date: May 25, 2023
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • DRUG ELUTING OCULAR IMPLANT WITH INTERNAL PLUG
    Publication number: 20230090539
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: November 30, 2022
    Publication date: March 23, 2023
    Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
  • IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
    Publication number: 20230053931
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: August 26, 2022
    Publication date: February 23, 2023
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • Implants with controlled drug delivery features and methods of using same
    Patent number: 11426306
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: August 30, 2022
    Assignee: DOSE MEDICAL CORPORATION
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • CONTROLLED DRUG DELIVERY OCULAR IMPLANTS AND METHODS OF USING SAME
    Publication number: 20220233349
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: February 18, 2022
    Publication date: July 28, 2022
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • Controlled drug delivery ocular implants and methods of using same
    Patent number: 11253394
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: February 22, 2022
    Assignee: Dose Medical Corporation
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
    Publication number: 20220000663
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: June 9, 2021
    Publication date: January 6, 2022
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • DRUG ELUTING OCULAR IMPLANT WITH INTERNAL PLUG
    Publication number: 20210298948
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: March 31, 2021
    Publication date: September 30, 2021
    Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
  • DRUG ELUTING OCULAR IMPLANT
    Publication number: 20210015662
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
  • Drug eluting ocular implant
    Patent number: 10813789
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: October 27, 2020
    Assignee: Dose Medical Corporation
    Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
  • IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
    Publication number: 20190314199
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: February 15, 2019
    Publication date: October 17, 2019
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • Implants with controlled drug delivery features and methods of using same
    Patent number: 10206813
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: February 19, 2019
    Assignee: Dose Medical Corporation
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • OCULAR IMPLANTS CONFIGURED TO STORE AND RELEASE STABLE DRUG FORMULATIONS
    Publication number: 20190021991
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. In several embodiments, the devices are configured to release a pro-drug form of a drug into a target tissue site, wherein the pro-drug is converted to an active drug that yields a therapeutic effect. The use of the device and pro-drug form advantageously, in several embodiments, provide a stable drug composition that can yield a therapeutic effect over an extended time period.
    Type: Application
    Filed: November 12, 2014
    Publication date: January 24, 2019
    Inventors: Harold A. Heitzmann, Kenneth M. Curry, David S. Haffner
  • THERAPEUTIC DRUG COMPOSITIONS AND IMPLANTS FOR DELIVERY OF SAME
    Publication number: 20180280194
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. In several embodiments, the devices are configured to release a pro-drug form of a drug into a target tissue site, wherein the pro-drug is converted to an active drug that yields a therapeutic effect. The use of the device and pro-drug form advantageously, in several embodiments, provide a stable drug composition that can yield a therapeutic effect over an extended time period.
    Type: Application
    Filed: May 18, 2016
    Publication date: October 4, 2018
    Inventors: Harold A. Heitzmann, Kenneth M. Curry, David S. Haffner, Timothy P. Murphy
  • IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
    Publication number: 20180193189
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: March 7, 2014
    Publication date: July 12, 2018
    Applicant: Dose Medical Corporation
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • CONTROLLED DRUG DELIVERY OCULAR IMPLANTS AND METHODS OF USING SAME
    Publication number: 20180177633
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: February 20, 2018
    Publication date: June 28, 2018
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
    Publication number: 20180021170
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: February 16, 2017
    Publication date: January 25, 2018
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry
  • DRUG ELUTING OCULAR IMPLANT
    Publication number: 20170281409
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: June 5, 2017
    Publication date: October 5, 2017
    Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
  • DRUG ELUTING OCULAR IMPLANT WITH INTERNAL PLUG
    Publication number: 20170135857
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Application
    Filed: February 1, 2017
    Publication date: May 18, 2017
    Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
  • Implants with controlled drug delivery features and methods of using same
    Patent number: 9603738
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more, drugs and may also Include structures which allow for treatment of Increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: March 28, 2017
    Assignee: DOSE MEDICAL CORPORATION
    Inventors: David S. Haffner, Thomas W. Burns, Harold A. Heitzmann, Kenneth M. Curry